Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid and Triamcinolone in Oral Lichen Planus
NCT06332365Completed
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Hydrogel Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyaluronic acid sodium composite gel for injection in oral lichen planus (OLP) (3 arms). Primary endpoint: Pain assessment scale at 4 weeks. Started Jan 2022; status: completed.
02
Drugs
hyaluronic acid sodium composite gel for injection
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06332365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06332365.